1.1 Introduction
Hepatitis B virus (HBV) is a DNA virus belonging to the Hepadnaviridae family that infects the liver and causes both acute and chronic hepatitis, which may progress to liver cirrhosis and hepatocellular carcinoma if not properly managed (World Health Organization, 2023). The infection is primarily transmitted through contact with infected blood and body fluids, making blood transfusion one of the significant routes of transmission when proper screening is not adequately implemented.
HBV remains one of the most serious infectious diseases affecting global public health, particularly in developing countries where routine screening and advanced diagnostic methods are often limited. Blood transfusion is an essential component of modern healthcare used in the management of trauma, surgical procedures, obstetric complications, and chronic diseases. However, the safety of blood transfusion depends largely on the effectiveness of screening methods used to detect transfusion-transmissible infections such as HBV (Olayinka et al., 2016).
As a prelude to other parts of this study, this chapter will discuss the background upon which this study was initiated, the statement of problems that led to this study, the Aim and Objectives of the study. Others are significance of the study, scope of work, research hypothesis and questions, limitation of the study and definition of terms.
1.2 Background of Study
Hepatitis B virus (HBV) is a DNA virus that infects the liver and is recognized as one of the most significant causes of chronic liver disease globally. According to the World Health Organization (WHO, 2023), HBV infection affects approximately 296 million people worldwide, with about 1.5 million new infections occurring annually, making it a persistent global health challenge. The infection is transmitted through exposure to infected blood and body fluids, including unsafe blood transfusion, which remains a major route of transmission in regions with limited diagnostic capacity.
According to Olayinka et al. (2016), HBV remains highly endemic in Nigeria, with varying prevalence rates reported across different population groups, including blood donors. The authors reported that despite ongoing public health interventions, the country continues to record significant cases of hepatitis B infection, largely due to inadequate screening methods and poor awareness among the population. This situation poses a major concern for blood transfusion services, as apparently healthy individuals may still carry and transmit the virus unknowingly.
Blood transfusion is an essential medical procedure that supports life-saving interventions in cases of trauma, surgery, anemia, obstetric emergencies, and chronic illnesses. However, its safety depends heavily on the effectiveness of screening processes used to detect transfusion-transmissible infections such as HBV. According to Kohn et al. (2020), safe blood transfusion practices require highly sensitive diagnostic tools capable of detecting infections even during the early stages of viral exposure. The authors asserted that reliance on conventional serological testing alone may not be sufficient to eliminate the risk of HBV transmission through blood transfusion.
In many developing countries, including Nigeria, blood screening is primarily carried out using serological methods that detect hepatitis B surface antigen (HBsAg). According to Centers for Disease Control and Prevention (CDC, 2022), HBsAg testing is effective for identifying active infections but may fail to detect cases during the window period, when the virus is present but antigen levels are too low for detection. This limitation increases the risk of transfusion-transmitted HBV, especially in settings where advanced diagnostic techniques are not routinely applied.
According to Olokoba et al. (2019), the prevalence of HBV among blood donors in Nigeria remains a major concern for public health authorities. The authors stated that a significant proportion of donors who are considered healthy based on routine screening still test positive for HBV markers when more sensitive diagnostic methods are applied. This finding highlights the presence of occult infections that are not detectable through standard screening procedures.
Molecular diagnostic techniques, particularly polymerase chain reaction (PCR), have been recognized as more reliable tools for detecting HBV infection. According to Tiwari et al. (2021), PCR-based methods detect viral DNA directly in blood samples, allowing for early identification of infection even at low viral loads. The authors affirmed that molecular detection significantly improves the accuracy of blood screening and reduces the risk of false-negative results associated with serological testing.
According to Adeyemi et al. (2020), the Nigerian Red Cross Blood Bank plays a vital role in the national blood supply system, yet it faces challenges related to ensuring the complete safety of donated blood. The authors contended that improving blood screening practices through the integration of molecular detection methods would significantly enhance the safety and reliability of blood transfusion services in the country. On the other hand, failure to adopt more sensitive diagnostic approaches continues to expose recipients to the risk of HBV infection, thereby increasing the burden of liver disease in the population.
In Nigeria, the need for improved blood safety systems is further emphasized by the high demand for blood transfusion services and the limited availability of safe blood. According to National Blood Service Commission (NBSC, 2021), ensuring the safety of donated blood remains a top priority, but challenges such as inadequate funding and technological limitations continue to affect service delivery. The authors stated that strengthening laboratory capacity and adopting molecular diagnostic techniques would significantly reduce transfusion-related risks.
This study is set against the backdrop of increasing concerns over transfusion-transmitted infections, particularly hepatitis B virus, and the need to improve diagnostic accuracy in blood screening processes within the Nigerian Red Cross Blood Bank.
1.3 Statement of Problems
Investigation revealed that HBV remains a major global public health concern, particularly in sub-Saharan Africa where the burden of infection is persistently high and transmission through blood transfusion continues to pose a serious threat to healthcare safety. The World Health Organization reports that HBV infection affects hundreds of millions of people worldwide, with a significant proportion of cases remaining undiagnosed due to asymptomatic carriage and limited access to sensitive diagnostic tools (WHO, 2023). In Nigeria, the prevalence among blood donors is still worrisome, with studies indicating varying rates that reflect ongoing community transmission and inadequate detection at the point of blood donation (Olayinka et al., 2016).
Additionally, blood transfusion services, including the Nigerian Red Cross Blood Bank, rely largely on routine serological screening methods that primarily detect hepatitis B surface antigen, which may not identify infections during the window period when the virus is present but not yet detectable by conventional assays.
Furthermore, the persistent circulation of HBV among apparently healthy blood donors suggests a hidden reservoir of infection within the population, which complicates efforts toward achieving safe blood transfusion practices. The implication is that recipients of blood transfusion remain at avoidable risk of HBV infection, thereby undermining public confidence in blood safety systems and increasing the long-term burden on healthcare delivery. It is against this backdrop that this study seeks to determine the prevalence of hepatitis B virus among blood donors using molecular diagnostic techniques.
1.4 Aim and Objectives of Study
The aim of this study is to assess the prevalence of hepatitis B virus among blood donors using molecular diagnostic techniques at the Nigerian Red Cross Blood Bank. In achieving this aim, the following specific objectives were laid out as follows:
- To determine the prevalence of hepatitis B virus among blood donors using molecular detection methods.
- To compare molecular detection results with conventional serological screening results.
- To identify the proportion of occult HBV infections among apparently healthy donors.
- To evaluate the effectiveness of existing HBV screening methods used in the blood bank.
- To assess the need for integration of molecular diagnostic techniques into routine blood screening.
1.5 Research Questions
The study came up with research questions so as to be able to ascertain the above stated objectives. The specific research questions for the study are stated below as follows:
- What is the prevalence of hepatitis B virus among blood donors using molecular detection methods?
- How do molecular detection results compare with conventional serological screening results?
- What proportion of blood donors have occult hepatitis B infection?
- How effective are the existing HBV screening methods in detecting infection?
- Why is there a need to integrate molecular diagnostic techniques into routine blood screening?
1.6 Research Hypotheses
In order to pursue the objective of this study, the following generalized statements have been designed to guide and aids in obtaining the result for the experiment to be conducted. For this work, the null hypothesis will be represented with H0 while the alternative hypothesis will be represented with hypothesis H1.
Hypothesis One
- H0: There is no significant prevalence of hepatitis B virus among blood donors using molecular detection methods.
- H1: There is a significant prevalence of hepatitis B virus among blood donors using molecular detection methods.
Hypothesis Two
- H0: There is no significant difference between molecular detection and serological screening results.
- H1: There is a significant difference between molecular detection and serological screening results.
Hypothesis Three
- H0: There is no significant presence of occult hepatitis B infection among blood donors.
- H1: There is a significant presence of occult hepatitis B infection among blood donors.
Hypothesis Four
- H0: Existing screening methods are not significantly effective in detecting hepatitis B virus.
- H1: Existing screening methods are significantly effective in detecting hepatitis B virus.
Hypothesis Five
- H0: There is no significant need to integrate molecular diagnostic techniques into routine screening.
- H1: There is a significant need to integrate molecular diagnostic techniques into routine screening.
1.7 Significance of Study
It is believed that at the completion of the study, the findings will provide reliable data on the hidden burden of hepatitis B virus among blood donors at the Nigerian Red Cross Blood Bank. The study will also assist in improving blood transfusion safety by supporting the adoption of molecular diagnostic techniques in screening processes.
Furthermore, the research will help health authorities strengthen policies on transfusion-transmissible infection control in Nigeria. In addition, the findings will contribute to improved diagnostic accuracy in blood screening systems.
Lastly, the findings will serve as a reference for future research on molecular detection of infectious diseases in blood donation systems.
1.8 Scope of Study
The study is focused on molecular detection of hepatitis B virus among blood donors in the Nigerian Red Cross Blood Bank, Rivers State, Nigeria, and does not extend to other blood-borne infections or other states in Nigeria.
1.9 Limitations of the Study
During the course of this study, there were some problems encountered which stood as limitations to the research work. Some of the limitations include:
- Time Constraint: The time frame given to accomplish this project was very short due to school academic calendar and it was carried out under pressure which made the researcher not to implement some necessary features.
- Financial Constraint: Insufficient fund tends to impede the efficiency of the researcher in sourcing for the relevant materials, literature or information and in the process of data collection (internet, questionnaire and interview).
- Initial Cooperation Delay from Respondents: A particular limitation of this work came as a result of the respondent refusal to offer their cooperation at the initial time they were contacted. This contributed in making the success of this research study difficult.
1.10 Definition of Terms
Molecular Detection:
Molecular Detection refers to the use of advanced laboratory techniques such as polymerase chain reaction (PCR) to identify the presence of viral genetic material in blood samples. According to CDC (2022), molecular methods provide higher sensitivity compared to conventional serological tests.
Hepatitis B Virus (HBV):
Hepatitis B Virus (HBV) is a DNA virus that infects the liver and may cause both acute and chronic liver disease. According to WHO (2023), HBV is a major global health concern due to its potential to cause liver cirrhosis and cancer.
Blood Donor:
Blood Donor refers to an individual who voluntarily gives blood for transfusion or medical use. According to NBSC (2021), safe donor screening is essential to ensure transfusion safety.
Serological Screening:
Serological Screening is a diagnostic method used to detect antigens or antibodies in blood samples. According to Olayinka et al. (2016), it is commonly used in blood banks but may not detect early infections.
…